Recognizing the need, urgency, and timeliness of real-world data to advance precision oncology, the AACR provided the seed money for the first phase of AACR Project GENIE. We are grateful to the following industry partners who have joined us in this endeavor and appreciate their continued support. Read more about our collaboration.

Interested in partnering?

Industry partners are invited to participate in the BioPharma Collaborative or explore targeted sponsored research opportunities. Contact us to discover how your organization can help shape the future of precision oncology with GENIE.